Andrew Reardon insider trades

Open-market stock purchases and sales by Andrew Reardon, CLO & Secretary at Ligand Pharmaceuticals Inc, from SEC Form 4 filings since Nov 30, 2022.

Recent trades

DateStockTradeValue
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$110K
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$152K
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$324K
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$90.7K
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$133K
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$279K
Jun 1, 2026LGND Ligand Pharmaceuticals IncSold$46.1K
Jun 1, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
May 1, 2026LGND Ligand Pharmaceuticals IncSold$136K
May 1, 2026LGND Ligand Pharmaceuticals IncSold$213K
May 1, 2026LGND Ligand Pharmaceuticals IncSold$22.5K
May 1, 2026LGND Ligand Pharmaceuticals IncSold$85.4K
May 1, 2026LGND Ligand Pharmaceuticals IncSold$181K
May 1, 2026LGND Ligand Pharmaceuticals IncSold$331K
May 1, 2026LGND Ligand Pharmaceuticals IncSold$187K
May 1, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Apr 1, 2026LGND Ligand Pharmaceuticals IncSold$91.5K
Apr 1, 2026LGND Ligand Pharmaceuticals IncSold$260K
Apr 1, 2026LGND Ligand Pharmaceuticals IncSold$249K
Apr 1, 2026LGND Ligand Pharmaceuticals IncSold$141K
Apr 1, 2026LGND Ligand Pharmaceuticals IncSold$196K
Apr 1, 2026LGND Ligand Pharmaceuticals IncSold$68.9K
Apr 1, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$19.9K
Mar 4, 2026LGND Ligand Pharmaceuticals IncSold$60.5K

Companies traded

  • LGND Ligand Pharmaceuticals Inc: 37 sales, last Jun 1, 2026

Get free alerts when Andrew Reardon files a new trade →